Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptor

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

Small molecule mu agonists based on the 4-phenyl piperidine scaffold were designed and synthesized to further investigate the therapeutic potential of loperamide analogs. The resulting compounds show excellent agonistic activity towards the human mu receptor with interesting SAR trends within the series.

Knowledge Graph

Similar Paper

Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptor
Bioorganic & Medicinal Chemistry Letters 2004.0
N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: The development of diaryl amino piperidines as potent δ opioid receptor agonists with in vivo anti-nociceptive activity in rodent models
Bioorganic & Medicinal Chemistry Letters 2009.0
trans -3,4-Dimethyl-4-(3-carboxamidophenyl)piperidines: A novel class of μ-Selective opioid antagonists
Bioorganic & Medicinal Chemistry Letters 2003.0
The xanthene-9-spiro-4'-piperidine nucleus as a probe for opiate activity
Journal of Medicinal Chemistry 1989.0
Synthesis and Pharmacological Evaluation of Novel Octahydro-1H-pyrido[1,2-a]pyrazine as μ-Opioid Receptor Antagonists
Journal of Medicinal Chemistry 2006.0
Design and Synthesis of Novel α<sub>1</sub><sub>a</sub> Adrenoceptor-Selective Antagonists. 2. Approaches To Eliminate Opioid Agonist Metabolites via Modification of Linker and 4-Methoxycarbonyl-4-phenylpiperidine Moiety
Journal of Medicinal Chemistry 1999.0
Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel μ opioid receptor ligands
Bioorganic &amp; Medicinal Chemistry Letters 2000.0
Pharmacophore-Based discovery, synthesis, and biological evaluation of 4-phenyl-1-arylalkyl piperidines as dopamine transporter inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2001.0
Designing bifunctional NOP receptor–mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II
Bioorganic &amp; Medicinal Chemistry 2014.0
A potent new class of .kappa.-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines
Journal of Medicinal Chemistry 1993.0